Accurate and cost-effective identification of circulating cancer cells to improve patient care by early diagnosis of cancer.
Team Cell was launched in the spring of 2012 in an effort to provide better healthcare technologies to patients worldwide. Our flagship diagnostic device, CTC-Sure, identifies circulating cancer cells with a speed, accuracy, and sensitivity far surpassing existing technologies on the market. This means improved patient outcomes while saving time and costs for healthcare providers. Team Cell currently operates out of Boston, MA and Madrid, Spain.